The oversubscribed round was led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, and current investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. The current Series A round follows a financing by Flashpoint Growth Debt Fund received in 2023.

Segmed collaborates with life-sciences, health care and technology firms to streamline access to medical imaging studies for advancing biopharmaceutical R&D, AI development and enhancing global health care initiatives. Segmed acquires, de-identifies, standardizes and subsequently provides medical imaging data to researchers and innovators in AI/ML and Real-World Imaging Data (RWiD) through its proprietary data platform. Before Segmed, acquiring imaging data for medical research was a time-consuming process that could take months, or even years. By partnering with thousands of health care locations and imaging clinics across five continents, researchers and AI developers can access the studies they need.